Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells. Kim Y, Ham B, Kim Y, Jung BH, et al. Biochem Biophys Res Commun 2026;821:153785.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim Y, Ham B, Kim Y, Jung BH, et al. Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells. Biochem Biophys Res Commun 2026;821:153785.
PMID: 42092220